IRCT138807052474N2已完成未知
The Effect of prethrombolytic Cyclosporine A injection on Acute Anterior ST-Elevation Myocardial Infarction Outcome.
Research vice-chancellor of Tabriz University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 85 years（—）
- 性别
- All
入选标准
- •Inclusion criteria : in patients with 18 years of age or older, presence of ischemic chest pain and ST segment elevation of 1 mm or more in at least two contiguous leads of anterior region, who admits in primary six hours of symptoms onset and candidate for thrombolytic therapy
- •Exclusion criteria : cardiac arrest, primary VF, prior MI, uncontrolled HTN, known hypersensitivity to cyclosporine, known renal failure or a serum creatinine level of 120 mol per liter (1.36 mg per deciliter) or more at admission, liver failure, and women who were pregnant or who were of childbearing age and were not using contraception, any disorder that is associated with immunologic dysfunction e.g., cancer, lymphoma, a positive serologic test for the human immunodeficiency virus, or hepatitis
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Neuroprotection Impact of Cyclosporin A in Cerebral InfarctionStrokeNCT01527240Hospices Civils de Lyon126
招募中
3 期
The effect of Cyclosporine in prognosis and clinical improvement in patients with COVID-19IRCT20200426047206N3Hamedan University of Medical Sciences48
已完成
不适用
A phase II trial of Cyclosporin A in early adverse risk Chronic Lymphocytic Leukaemia (CLL)Topic: National Cancer Research NetworkSubtopic: Haematological OncologyDisease: Leukaemia (chronic)Chronic lymphocytic leukaemia of B-cell typeCancerISRCTN61297219niversity of Birmingham (UK)5
进行中（未招募）
1 期
An early phase trial of Cyclosporin A in patients with early stage Chronic Lymphocytic Leukaemia (CLL) who do not currently require treatment.EUCTR2012-002795-13-GBniversity of Birmingham5
进行中（未招募）
不适用
A trial looking at how well locally applied ciclosporin can support the healing after non-surgical treatment of chronic periodontitisModerate to severe chronic periodontitisEUCTR2014-002625-35-SEPerioC Ltd